| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/26/1989 | WO1989000692A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/26/1989 | WO1989000582A2 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 01/26/1989 | WO1989000575A1 Platinum compounds suitable for use as pharmaceuticals |
| 01/26/1989 | WO1989000574A1 Platinum pharmaceuticals |
| 01/26/1989 | WO1989000427A1 Pharmaceutical therapeutic use of a glutathione derivative |
| 01/26/1989 | DE3823066A1 Rolliniastatin 1, ein diastereomeres bis-tetrahydrofuran-asimycin aus rollinia mucosa, verfahren zu seiner gewinnung und verwendung als antineoplastisches mittel Rolliniastatin 1, a diastereomeric bis-tetrahydrofuran-asimycin from Rollinia mucosa, process for its manufacture and use as an antineoplastic medium |
| 01/25/1989 | EP0300812A2 Platinum triamine antitumor agents containing saturated amines |
| 01/25/1989 | EP0300749A2 Injectable formulation containing 3-benzoyloxy-1,3,5(10)-estratriene-17-[4-[p-(bis(2-chloroethyl)amino)phenyl]-butanoyloxy]acetate |
| 01/25/1989 | EP0300294A2 Novel compound DC-107 and process for its preparation |
| 01/24/1989 | CA1249278A1 6-substituted mitomycin analogs |
| 01/19/1989 | DE3822557A1 Somatostatins |
| 01/19/1989 | DE3722647A1 Galenische verwendung eines tripeptids als arzneimittel Pharmaceutical use of a tripeptide as drug |
| 01/18/1989 | EP0299782A2 Expression vectors for the production of human Granulocyte-Macrophage Colony Stimulation Factor in a mammalian cell host(18.05.92) |
| 01/18/1989 | EP0299761A1 Anti-inflammatory aryl derivatives |
| 01/18/1989 | EP0299745A2 Double-stranded RNA correction of RNase L deficiency |
| 01/18/1989 | EP0299713A2 Antiviral, antitumor and antifungal compositions |
| 01/18/1989 | EP0299683A2 Heterocyclic olefinic compounds and their use as aromatase inhibitors |
| 01/18/1989 | EP0299528A1 Doxorubicin hydrochloride nonaqueous solution |
| 01/18/1989 | EP0299527A1 Doxorubicin hydrochloride aqueous solutions |
| 01/18/1989 | EP0299467A1 Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction |
| 01/18/1989 | EP0299350A2 Anthracyclin derivatives with cytostatic activity |
| 01/18/1989 | EP0299206A2 Recombinant human ADF |
| 01/18/1989 | EP0299057A1 Potentiation of cytotoxic conjugates |
| 01/18/1989 | EP0298989A1 Treatment of cancer with interferon and radiotherapy |
| 01/17/1989 | US4798833 Guanine derivative |
| 01/17/1989 | CA1248897A1 Tetracyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 01/17/1989 | CA1248874A1 Process for the preparation of antitumoral glycoproteins modified on their carbohydrate units |
| 01/12/1989 | WO1989000194A1 Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides |
| 01/12/1989 | WO1989000051A1 Fibrin-binding compound and method |
| 01/12/1989 | WO1989000050A1 Antigen recognized by mca 16-88 |
| 01/11/1989 | EP0298820A1 Peptide derivatives and their therapeutic application |
| 01/11/1989 | EP0298732A2 Therapeutic Somatostatin analogues |
| 01/11/1989 | EP0298555A1 Process for synthesis of aminomethylene phosphonoalkylphosphinates |
| 01/11/1989 | EP0298553A1 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| 01/11/1989 | EP0298436A2 Use of a vehicle with a high tumour affinity |
| 01/11/1989 | EP0298385A2 Cyctostatic anthracyclin derivatives |
| 01/10/1989 | US4797929 Word recognition in a speech recognition system using data reduced word templates |
| 01/10/1989 | US4797485 1,2-cyclohexanediamine and similar amines as ligands |
| 01/10/1989 | US4797397 X-rays therapy of tumors |
| 01/10/1989 | US4797393 Antitumor agents |
| 01/10/1989 | US4797388 Pharmaceutical compositions with galactitol as carrier |
| 01/10/1989 | CA1248535A1 Lecithin-analog phospholipids having antitumor and antifungal activities |
| 01/10/1989 | CA1248534A1 Ketoalkylphospholipids |
| 01/10/1989 | CA1248453A1 Pharmaceutical compositions containing anthracycline glycosides |
| 01/04/1989 | EP0297995A1 Polycyclic aromatic compounds, process for their preparation and their use in human and animal medicine and in cosmetics |
| 01/04/1989 | EP0297946A2 Cytochalasin purification methods and compositions |
| 01/04/1989 | EP0297833A2 Physiologically active lymphotoxin |
| 01/04/1989 | EP0297733A2 Pharmaceutical compositions comprising catecholic butanes |
| 01/04/1989 | EP0297594A2 Novel 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives |
| 01/04/1989 | EP0297585A2 Neuronal polypeptide and methods of production and use thereof |
| 01/04/1989 | CN1030074A Leukotriene antagonists |
| 01/03/1989 | US4795814 Process for preparing novel dihydropyridine derivatives |
| 01/03/1989 | CA1248298A1 Amino-thioalkyl structured radiation protection agents and their preparation |
| 01/03/1989 | CA1248116A1 Biologically active substance called girolin, extracted from a sponge (pseudodaxinyssa cantharella), preparation process and pharmaceutical compositions containing same |
| 01/03/1989 | CA1248106A1 METHOD FOR PREPARING BENZO¬.alpha.|PHENAZINE DERIVATIVES |
| 01/03/1989 | CA1248105A1 Sparsomycin (s.sub.c-r.sub.s) derivative; pharmaceutical composition having anti-tumor activity |
| 01/03/1989 | CA1248024A1 Treatments employing drug-containing matrices for introduction into cellular lesion areas |
| 12/29/1988 | WO1988010266A1 Cysteine proteinase inhibitor |
| 12/29/1988 | WO1988010259A1 Cytochalasin purification methods and compositions |
| 12/28/1988 | EP0296848A1 Biological response modifiers, their production, and their use in therapy or in prophylaxis |
| 12/28/1988 | EP0296811A2 Carbamates of 4-hydroxyanisole as prodrugs for chemotherapy of melanoma |
| 12/28/1988 | EP0296749A1 (Substituted aralkyl) heterocyclic compounds |
| 12/28/1988 | EP0296732A1 Leukotriene antagonists |
| 12/28/1988 | EP0296321A1 Synthesis of cisplatinum analogs |
| 12/28/1988 | EP0296222A1 A method of modifiying the metabolism of eukaryotic cells upon incorporation therein of foreign sequences of nucleic acids by means of an internalizing vector |
| 12/28/1988 | CN88102182A Method for preparation of 4-demethoxy-4-amino anthracene compounds |
| 12/27/1988 | US4794183 Certain tetrahydro-furan or pyran phosphate-ethylene or propylene ammonium derivatives |
| 12/27/1988 | US4793986 Polysaccharide carrier, activated, linked to platinum compound through amine-containing ligand |
| 12/21/1988 | EP0296122A2 Cyclosporins and their use as pharmaceuticals |
| 12/21/1988 | EP0296110A2 Staurosporine derivatives substituted for the nitrogen atom of the methylamino group |
| 12/21/1988 | EP0296097A2 Medicine containing inhibitors of the progesterone synthesis of the trilostane or epostane type and antigestagens |
| 12/21/1988 | EP0296059A1 Tripeptides with a polycyclic nitrogen strusture, their process of preparation and the pharmaceutical compositions thereof |
| 12/21/1988 | EP0295559A2 Pharmaceutical composition for the treatment of tumours |
| 12/21/1988 | EP0295317A1 Pharmaceutical composition for the treatment of tumors |
| 12/21/1988 | EP0295316A2 Antitumor amino acid and peptide derivatives of 1,4-bis[ (aminoalkyl and hydroxyaminoalkyl)- amino]-5,8 dihydroxyanthraquinones |
| 12/21/1988 | EP0295284A1 Compositions containing sulphur prostaglandines |
| 12/20/1988 | US4792566 In-vial deposition of 7-(dimethylaminomethylene)amino-9α-methoxymitosane |
| 12/20/1988 | CA1247132A1 2,6-disubstituted naphthalene derivatives and process for preparing the same |
| 12/20/1988 | CA1247123A1 Polysubstituted derivatives of naphtalene, and their preparation |
| 12/20/1988 | CA1247122A1 Unsaturated camphor derivatives, and their preparation |
| 12/20/1988 | CA1247094A1 7-deazapurine derivatives and their production |
| 12/20/1988 | CA1247084A1 Peptide process for preparation thereof and use thereof |
| 12/15/1988 | WO1988009815A1 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation |
| 12/15/1988 | WO1988009810A1 Novel amphiphilic nucleic acid conjugates |
| 12/15/1988 | WO1988009797A1 Autocrine motility factors in cancer diagnosis and management |
| 12/15/1988 | WO1988009674A1 Stabilized formulations of gamma interferons |
| 12/14/1988 | EP0295161A1 3-Acylaminomethyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine derivatives, their preparation and therapeutical use |
| 12/14/1988 | EP0294828A2 Mitomycin analogs, a process for preparing them and pharmaceutical compositions |
| 12/14/1988 | EP0294703A2 Bifunctional antibody constructs and method for selectively destroying cell populations |
| 12/14/1988 | EP0294491A1 Antibiotic yi-hu3 and process for its preparation |
| 12/14/1988 | CN88103408A Process for preparing (1h-imidzol-1-ylmethyl) substituted benzotriazole derivatives |
| 12/13/1988 | US4791130 Mitomycin derivatives as antileukemia agents |
| 12/13/1988 | US4791128 Rhizoxin esters and salts, their pharmaceutical use as anti-tumor agents |
| 12/13/1988 | CA1246577A1 Camptothecin-1-oxide derivatives and process for preparing same |
| 12/13/1988 | CA1246451A1 Etoposide soft capsules |
| 12/07/1988 | EP0294238A1 Novel 1-alkyl-1-sulfonyl-2-alkoxycarbonylsulfenylhydrazines having antineoplastic activity |
| 12/07/1988 | EP0294021A1 Human somatomedin carrier protein subunits and process for producing them |
| 12/07/1988 | EP0293978A2 (1H-azol-1-ylmethyl)substituted benzotriazole derivatives |
| 12/07/1988 | EP0293940A1 Monoclonal antibody and method for preparation of hybridoma producing said antibody |
| 12/07/1988 | EP0293785A2 Cloning and expression of simian transforming growth factor-SS1 |